#BioTools
🚨 JUST IN: $LAB
Standard BioTools holders approve Treeline merger, reverse split up to 1-for-40, Mass Cytometry sale

#SEC #stocks #investing #LAB #Mergers
🔗 secwatch.observer
November 19, 2026 at 11:36 PM
STANDARD BIOTOOLS INC. (0001162194) (Filer) (cik: 0001162194) filed an 8-K update with an Item 5.02. See the filing at https://www.sec.gov/Archives/edgar/data/1162194/000114036126044934/0001140361-26-044934-index.htm
November 19, 2026 at 10:22 PM
Today's stories worth knowing:

$LAB · Bad for LAB: Standard BioTools Inc. shared news about a lawsuit connected to its…
RDZN · Good for RDZN: Roadzen Inc. shared its second-quarter results, showing record…
Latest stock news, explained
Explained in plain English on Market News AI. Educational, not investment advice.
marketnewsai.com
November 16, 2026 at 9:40 PM
Standard Biotools ($LAB) – Insider Purchase

• Insider: Thomas D. Carey, Director
• Bought: 75,000 shares (about $47K)
• Price: about $0.63 a share · Nov 5
• Now Holds: 419,456 shares directly

📊 More at www.elixstocks.com

Educational only. Not investment advice.

#InsiderBuying #Stocks
Thomas D. Carey (Director) bought $47K of Standard Biotools ($LAB)
Form 4 filed Nov 5. Every line of the filing.
elixstocks.com
November 5, 2026 at 10:37 PM
🚨 $LAB
On November 3, 2026, Standard BioTools Inc., a Delaware corporation , issued a joint press release with ARCHIMED, a leading investment firm focused exclusively on healthcare industries , announcing the closing of Standard BioTools’ previously announced sale of its Microfluidics business to...
SEC Filing: LAB
Click to view the official SEC document.
www.sec.gov
November 3, 2026 at 1:23 PM
Mark Nitz and Mitchell Winnik have won the NSERC Synergy Award for their 20-year university-industry collaboration with Standard BioTools.

Learn more: www.artsci.utoronto.ca/news/chemist...
October 29, 2026 at 4:23 PM
⚠️ $LAB Standard BioTools / Related-party conflict and deal risk: All-stock reverse merger with Treeline (LAB holders ~16%, Treeline ~84%); Casdin Capital owns ~23% of LAB and is also a Treeline investor, prompting special committee review; closing not co...
October 21, 2026 at 12:00 PM
eGlint, Inc. Receives 2026 BioTools Innovator Grand Prize for Proteomics Breakthrough#United_States#San_Diego#BioTools#eGlint#ProteoNex
eGlint, Inc. Receives 2026 BioTools Innovator Grand Prize for Proteomics Breakthrough
eGlint, Inc. has been awarded the prestigious 2026 BioTools Innovator Grand Prize, showcasing its innovative ProteoNex™ biosensor technology aimed at transforming proteomics.
third-news.com
October 19, 2026 at 4:57 PM
New Chapter at BioTools

I'm thrilled to share that I've started a new chapter in my career at BioTools Co., Ltd. (圖爾思生物科技) as a Sales Specialist in the Industrial Group.

Looking forward to meeting more old friends and new connections in this new journey!
October 19, 2026 at 2:29 PM
At BioTools, we provide a wide range of life science services, including:
🔬 Proteomics
🧪 Multiplex ELISA
🧫 Customized Antibody
🧬 Telomere Length Analysis
🧬 Gene & Peptide Synthesis
🧬 RNA Sequencing (RNA-seq)
…and many other customized research services.
October 19, 2026 at 2:29 PM
The deal is part of Standard BioTools' strategy to sell off various business segments in preparation for its merger with Treeline Biosciences.
Standard BioTools to Sell Microfluidics Business to Archimed
Standard BioTools to Sell Microfluidics Business to Archimed
ebx.sh
October 6, 2026 at 3:13 PM
🚨 $LAB
On October 5, 2026, Standard BioTools Inc., a Delaware corporation , issued a press release announcing that it has entered into a definitive agreement with respect to the sale of its Microfluidics business to ARCHIMED, a leading investment firm focused exclusively on healthcare industries.
SEC Filing: LAB
Click to view the official SEC document.
www.sec.gov
October 5, 2026 at 8:53 PM
Standard BioTools has now agreed to sell its mass cytometry business to Element Biosystems, replacing a previously announced deal with Multiplex Bio.
Standard BioTools Inks New Agreement to Sell Mass Cytometry Business for $5.5M
Standard BioTools Inks New Agreement to Sell Mass Cytometry Business for $5.5M
ebx.sh
October 1, 2026 at 4:37 PM
FDA changed one word: "animal" became "nonclinical." What it means for NAMs, bioprinting and biotools, in this week's Lattice Brief. 3dheals.com/did-fda-just...
Did FDA just increased the biotools market | The Lattice Brief (9/27/26)
Explore how the FDA's new rules impact Biotools and animal-free testing in pharmaceutical development and research.
3dheals.com
September 29, 2026 at 9:05 PM
📦 amelaye/biotools v1.1.1

Symfony forms and services for the BioPHP minitools

🔗 https://github.com/amelaye/biotools
September 17, 2026 at 6:27 PM
New SEC filing | Sep 9, 2026 | 17:25 ET

LAB (Standard BioTools)
Definitive Proxy Filed for $2.5B Reverse Merger with Treeline Biosciences

💰 Current price: $0.7399
Chart reflects closing price
Importance Score: 9/10 | Sentiment: Neutral

Most traders won't see this until tomorrow's headline.
September 9, 2026 at 9:58 PM
Investor Alert: M&A Class Action Firm Reviews Major Acquisitions Involving Key Nasdaq Firms#United_States#New_York#VerifyMe#Iridium_Communications#Standard_Biotools
Investor Alert: M&A Class Action Firm Reviews Major Acquisitions Involving Key Nasdaq Firms
The M&A Class Action Firm investigates mergers involving Iridium, VerifyMe, Valaris, and Standard Biotools. Shareholders may have claims.
third-news.com
September 8, 2026 at 3:16 PM